Capricor Therapeutics Inc (CAPR)
18.14
-0.44
(-2.37%)
USD |
NASDAQ |
Nov 05, 10:33
Capricor Therapeutics Total Liabilities (Quarterly): 26.78M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 26.78M |
March 31, 2024 | 31.01M |
December 31, 2023 | 36.13M |
September 30, 2023 | 38.94M |
June 30, 2023 | 43.28M |
March 31, 2023 | 47.66M |
December 31, 2022 | 38.31M |
September 30, 2022 | 38.50M |
June 30, 2022 | 39.34M |
March 31, 2022 | 40.28M |
December 31, 2021 | 9.962M |
September 30, 2021 | 6.365M |
June 30, 2021 | 6.550M |
March 31, 2021 | 7.164M |
December 31, 2020 | 6.419M |
September 30, 2020 | 5.779M |
June 30, 2020 | 5.472M |
March 31, 2020 | 4.701M |
December 31, 2019 | 4.274M |
September 30, 2019 | 4.337M |
June 30, 2019 | 4.943M |
March 31, 2019 | 4.877M |
December 31, 2018 | 4.632M |
September 30, 2018 | 5.252M |
June 30, 2018 | 4.696M |
Date | Value |
---|---|
March 31, 2018 | 4.854M |
December 31, 2017 | 5.047M |
September 30, 2017 | 20.06M |
June 30, 2017 | 20.80M |
March 31, 2017 | 21.26M |
December 31, 2016 | 22.75M |
September 30, 2016 | 24.42M |
June 30, 2016 | 19.01M |
March 31, 2016 | 18.07M |
December 31, 2015 | 17.10M |
September 30, 2015 | 17.96M |
June 30, 2015 | 19.14M |
March 31, 2015 | 20.15M |
December 31, 2014 | 19.88M |
September 30, 2014 | 20.75M |
June 30, 2014 | 21.52M |
March 31, 2014 | 17.64M |
December 31, 2013 | 6.073M |
September 30, 2013 | 1.682M |
June 30, 2013 | 1.528M |
March 31, 2013 | 1.058M |
December 31, 2012 | 0.5292M |
September 30, 2012 | 0.468M |
June 30, 2012 | 0.4579M |
March 31, 2012 | 0.4853M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.274M
Minimum
Dec 2019
47.66M
Maximum
Mar 2023
23.00M
Average
26.78M
Median
Jun 2024
Total Liabilities (Quarterly) Benchmarks
Abbott Laboratories | 34.33B |
ResMed Inc | 2.027B |
enVVeno Medical Corp | 3.02M |
Regenxbio Inc | 221.11M |
AIM ImmunoTech Inc | 9.613M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 38.28M |
Shareholders Equity (Quarterly) | 11.50M |
Current Ratio | 1.372 |